IMRN

Immuron (IMRN)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMRN
DataOraFonteTitoloSimboloCompagnia
03/05/202412:00GlobeNewswire Inc.Immuron Director ResignationNASDAQ:IMRNImmuron Ltd
15/04/202412:00GlobeNewswire Inc.Immuron to host Live Virtual EventNASDAQ:IMRNImmuron Ltd
10/04/202412:00GlobeNewswire Inc.Immuron Travelan® sales continued strong growthNASDAQ:IMRNImmuron Ltd
07/03/202414:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
07/03/202412:00GlobeNewswire Inc.Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USNASDAQ:IMRNImmuron Ltd
21/02/202412:00GlobeNewswire Inc.Immuron Presentation Australian Biologics Festival 2024NASDAQ:IMRNImmuron Ltd
13/02/202412:00GlobeNewswire Inc.Immuron achieves record Travelan® salesNASDAQ:IMRNImmuron Ltd
08/02/202412:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
16/01/202412:00GlobeNewswire Inc.Immuron achieves record half yearly Travelan® salesNASDAQ:IMRNImmuron Ltd
22/12/202312:00GlobeNewswire Inc.Immuron Clinical Trials UpdateNASDAQ:IMRNImmuron Ltd
04/12/202312:00GlobeNewswire Inc.Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical StudyNASDAQ:IMRNImmuron Ltd
14/11/202300:00GlobeNewswire Inc.Immuron CEO Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
30/10/202312:21GlobeNewswire Inc.Immuron CEO Steven Lydeamore presented at AusBioInvestNASDAQ:IMRNImmuron Ltd
18/10/202312:00GlobeNewswire Inc.Immuron Announces Travelan® Clinical Study Cohort 2 commencesNASDAQ:IMRNImmuron Ltd
11/10/202312:00GlobeNewswire Inc.Immuron achieves record quarterly Travelan® salesNASDAQ:IMRNImmuron Ltd
28/09/202312:18Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:IMRNImmuron Ltd
13/09/202312:00GlobeNewswire Inc.Immuron achieves record monthly Travelan® salesNASDAQ:IMRNImmuron Ltd
11/09/202312:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to present at H.C. WainwrightNASDAQ:IMRNImmuron Ltd
14/08/202312:00GlobeNewswire Inc.Immuron to present at the Military Health System Research SymposiumNASDAQ:IMRNImmuron Ltd
25/07/202312:00GlobeNewswire Inc.Immuron Announces First Patients Enrolled in Travelan® Clinical StudyNASDAQ:IMRNImmuron Ltd
24/07/202312:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to present at BiosharesNASDAQ:IMRNImmuron Ltd
11/07/202312:00GlobeNewswire Inc.Immuron Business Update - Ateria Health launches Juvia™ in AustraliaNASDAQ:IMRNImmuron Ltd
05/07/202312:00GlobeNewswire Inc.Immuron FY23 Sales increase 136% on FY22 SalesNASDAQ:IMRNImmuron Ltd
30/06/202312:00GlobeNewswire Inc.Immuron Chairman TransitionNASDAQ:IMRNImmuron Ltd
22/06/202312:00GlobeNewswire Inc.Immuron Business Update: Letter to ShareholdersNASDAQ:IMRNImmuron Ltd
07/06/202314:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMRNImmuron Ltd
30/05/202312:00GlobeNewswire Inc.Immuron Initiates Recruitment of Travelan® Clinical StudyNASDAQ:IMRNImmuron Ltd
08/05/202316:25AllPennyStocks.comBiotech Shares Already Bid Up During Monday's PremarketNASDAQ:IMRNImmuron Ltd
08/05/202312:00GlobeNewswire Inc.Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial InitiationNASDAQ:IMRNImmuron Ltd
02/05/202312:00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore to present at Coffee MicrocapsNASDAQ:IMRNImmuron Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IMRN
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network